Vera Therapeutics Overview

  • Founded
  • 2011
Founded
  • Status
  • Public
  • Employees
  • 13
Employees
  • Stock Symbol
  • VERA
Stock Symbol
  • Share Price
  • $15.01
  • (As of Friday Closing)

Vera Therapeutics General Information

Description

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Contact Information

Website
www.veratx.com
Formerly Known As
PNA Innovations, CDF Therapeutics, Trucode Gene Repair
Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Stock Exchange
NAS
Primary Office
  • 170 Harbor Way
  • 3rd Floor
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Vera Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vera Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$15.01 $16.32 $11.30 - $33.45 $319M 21.3M 67.5K -$13.10

Vera Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 372,212
Revenue 0 0 0
EBITDA (55,296) (53,003) (11,452)
Net Income (55,486) (53,413) (11,854)
Total Assets 97,647 54,554 5,381
Total Debt 0 2 132
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vera Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vera Therapeutics‘s full profile, request access.

Request a free trial

Vera Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Vera Therapeutics‘s full profile, request access.

Request a free trial

Vera Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transfo
Drug Discovery
South San Francisco, CA
13 As of 2021
00000
0000 0000-00-00
00000000 00000

00000 00

ctetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim a
0000 00000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

0000000

enderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupi
0000 000000000
Waltham, MA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vera Therapeutics Competitors (67)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sutro Biopharma Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000000 Formerly VC-backed Waltham, MA 000 00000 000000 - 000 00000
0000000 0000000000 Formerly PE-Backed San Diego, CA 00 000 000000000 - 000
0000000 0000000000 Formerly VC-backed Boston, MA 0 00000 000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 67 competitors. Get the full list »

Vera Therapeutics Patents

Vera Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190298857-A1 Polymer-based nanoparticles, related formulations methods, and apparatus Pending 09-Jan-2018 00000000000
US-20190055190-A1 Peptide nucleic acid (pna) monomers with an orthogonally protected ester moiety and novel intermediates and methods related thereto Abandoned 17-Jul-2017 0000000000
EP-3655388-A1 Peptide nucleic acid (pna) monomers with an orthogonally protected ester moiety and novel intermediates and methods related thereto Pending 17-Jul-2017 0000000000
CA-3070058-A1 Peptide nucleic acid (pna) monomers with an orthogonally protected ester moiety and novel intermediates and methods related thereto Pending 17-Jul-2017 0000000000
US-20210171437-A1 Peptide nucleic acid (pna) monomers with an orthogonally protected ester moiety and novel intermediates and methods related thereto Pending 17-Jul-2017 C07C229/08

Vera Therapeutics Executive Team (9)

Name Title Board Seat Contact Info
Marshall Fordyce MD Chief Executive Officer & Board Member
Sean Grant Chief Financial Officer, Finance
Allen Ebens Ph.D Chief Scientific Officer
Joanne Curley Ph.D Executive
Lauren Frenz Executive
You’re viewing 5 of 9 executive team members. Get the full list »

Vera Therapeutics Board Members (10)

Name Representing Role Since
Andrew Cheng Ph.D Self Board Member 000 0000
Beth Seidenberg MD Self Board Member 000 0000
Joseph Walton Self Board Member 000 0000
Krishna Yeshwant MD Self Board Member 000 0000
Kurt von Emster Abingworth Management Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Vera Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vera Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vera Therapeutics‘s full profile, request access.

Request a free trial